Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

25.90
BATS BZX Real-Time Price
As of 9:34am ET
 -0.31 / -1.18%
Today’s Change
23.55
Today|||52-Week Range
263.81
-74.52%
Year-to-Date
Valeant Pharmaceuticals: New Documents Shed Light on the Philidor Fiasco
8:25am / MotleyFool.com - Paid Partner Content
Valeant Pharmaceuticals International (VRX) Showing Signs Of A Dead Cat Bounce Today
May 20 / TheStreet.com - Paid Partner Content
Allergan to do Smaller Deals and Boost Credit Rating
May 23 / TheStreet.com - Paid Partner Content
Valeant Receives Default Notice, Accelerating Reporting Deadlines
May 20 / TheStreet.com - Paid Partner Content
Valeant to Evaluate Sales of Noncore Assets
May 23 / TheStreet.com - Paid Partner Content
Doug's Morning Musings
May 20 / TheStreet.com - Paid Partner Content
Here's a Reason Why Valeant (VRX) Stock Is Down Today
May 23 / TheStreet.com - Paid Partner Content
Valeant (VRX) Stock Slumps, Receives Notice of Default
May 20 / TheStreet.com - Paid Partner Content
Valeant, Apple and Starbucks: Doug Kass' Views
May 23 / TheStreet.com - Paid Partner Content
U.S. Futures Rally Premarket, Close Week on High Note
May 20 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close26.21
Today’s open26.31
Day’s range25.24 - 26.51
Volume323,788
Average volume (3 months)26,005,199
Market cap$8.9B
Dividend yield--
Data as of 9:34am ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-15.97%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book1.52

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+2.25+1.52%
IDXXIDEXX Laboratories I...+1.49+1.69%
MDVNMedivation Inc+0.46+0.76%
RDYDr.Reddy's Laborator...-0.06-0.13%
Data as of 10:34am ET, 05/24/2016

Financials

Next reporting dateJune 10, 2016
EPS forecast (this quarter)$1.36
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer, Director &
Executive VP
Robert L. Rosiello
Corporate headquarters
Laval, Quă©bec

Forecasts

Partner Offers

Search for Jobs